Ultimate Guide to CLSI Document M45: Infrequently Isolated or Fastidious Bacteria
Antimicrobial breakpoints change. They are updated based on emerging resistance mechanisms and pharmacokinetic/pharmacodynamic (PK/PD) data. An old, free PDF from 2010 may list breakpoints for ciprofloxacin that are now considered dangerously high, leading to false-susceptible (very major) errors. clsi document m45 pdf
Using standard AST methods on fastidious or rare organisms can lead to inaccurate results. This can cause inappropriate patient treatment or unrecognized antibiotic resistance. Key Benefits of Implementing CLSI M45: Ultimate Guide to CLSI Document M45: Infrequently Isolated
When you are faced with "unusual" suspects—the infrequently isolated or fastidious bacteria—you need a different roadmap. That is where comes in. What is CLSI M45? clsi document m45 pdf
Here's a summary of the CLSI M45 standard: